Serum Bone Gla Protein and the Vitamin D Endocrine System in the Oophorectomized Rat
- 1 February 1988
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 122 (2) , 624-630
- https://doi.org/10.1210/endo-122-2-624
Abstract
Because of the importance of estrogen in osteoporosis, the effects of decreased estrogen production using sensitive measurements of bone mineral metabolism were studied in oophorectomized rats. Serum levels of ionized calcium, bone gla protein (BGP), vitamin D metabolites (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D), and estradiol were measured before and serially for 6 weeks after oophorectomy in the rat. In addition, static and dynamic indices of bone histomorphometry were determined after double tetracycline labeling. Fifty Sprague-Dawley female rats (.apprx. 250 g) were studied. Twenty-five rats underwent oophorectomy (O), while the remaining rats were sham operated. Estrogen deficiency was noted in the O group within a week after surgery (estradiol, 2.45 .+-. 0.78 vs. 27.9 .+-. 4.15 pg/ml; P < 0.05). Serum ionized calcium levels, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and PTH levels did not differ between the two groups during the length of the study. Serum BGP levels were the same in both groups until the second week postoophorectomy, after which BGP remained significantly elevated in the O animals (121.7 .+-. 5.95 vs. 76.7 .+-. 3.87; P < 0.001). Bone histomorphometry revealed increased osteoid volume (4.4 .+-. 0.9% vs. 2.3 .+-. 0.7%), osteoblast surface (26.5 .+-. 2.4% vs. 3.2 .+-. 1.2%), tetracycline surface (18.9 .+-. 4.1% vs. 6.8 .+-. 2.2%), as well as osteoclast surface (8.2 .+-. 1.4% vs. 2.5 .+-. 2%) in all O animals compared with those in the sham-operated group. These data indicate that oophorectomy and decreased estrogen result in increased bone turnover with elevated BGP levels. The marked BGP elevation withdrawal results in rapid altered bone mineral metabolism. The lack of concomitant increase in circulating PTH levels suggests that other factors may be mediating the bone loss following surgical oophorectomy.This publication has 20 references indexed in Scilit:
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985
- Role of parathyroid hormone and 1,25-dihydroxyvitamin D3 in the development of osteopenia in oophorectomized ratsCalcified Tissue International, 1982
- Total and Free Estrogens and Androgens in Postmenopausal Women with Hip Fractures*Journal of Clinical Endocrinology & Metabolism, 1982
- Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animalsAnalytical Biochemistry, 1981
- Effect of Estrogen on Calcium Absorption and Serum Vitamin D Metabolites in Postmenopausal Osteoporosis*Journal of Clinical Endocrinology & Metabolism, 1980
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- Absence of the vitamin K-dependent bone protein in fetal rat mineral. Evidence for another gamma-carboxyglutamic acid-containing component in bone.Journal of Biological Chemistry, 1980
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- Parathyroid Function in Primary OsteoporosisClinical Science, 1979
- Distinction between Alpha-Fetoprotein and Intracellular Estrogen Receptors: Evidence against the Presence of Estradiol Receptors in Rat Bone*Endocrinology, 1978